Pathogenetic mechanisms of amyloid A amyloidosis. - Wikidata - awgldk - TriplyDB

Pathogenetic mechanisms of amyloid A amyloidosis.

Pathogenetic mechanisms of amyloid A amyloidosis.

http://www.wikidata.org/entity/Q37218553

about

Secondary amyloidosis in autoinflammatory diseases and the role of inflammation in renal damage Functional Amyloid Signaling via the Inflammasome, Necrosome, and Signalosome: New Therapeutic Targets in Heart Failure Deficiency of endogenous acute phase serum amyloid A does not affect atherosclerotic lesions in apolipoprotein E-deficient mice Amyloidosis in a Captive Zebra Finch (Taeniopygia guttata) Research Colony Proteomic analysis of highly prevalent amyloid A amyloidosis endemic to endangered island foxes A novel TetR-regulating peptide turns off rtTA-mediated activation of gene expression Amyloid nephropathy Protein profiling of isolated uterine AA amyloidosis causing fetal death in goats.Hepatic expression of serum amyloid A1 is induced by traumatic brain injury and modulated by telmisartan Caloric restriction reduces the systemic progression of mouse AApoAII amyloidosis.Structure of serum amyloid A suggests a mechanism for selective lipoprotein binding and functions: SAA as a hub in macromolecular interaction networks.Amyloid persistence in decellularized liver: biochemical and histopathological characterization.Systemic Amyloid A Amyloidosis in Island Foxes (Urocyon littoralis): Severity and Risk Factors.Amyloid and inflammation.Acute fatal metabolic complications in alkaptonuria.Serum amyloid A1: Structure, function and gene polymorphism.Recent refinements to cranial implants for rhesus macaques (Macaca mulatta)Amyloid associated with neoplasia in two captive tricolour sharkminnows Balantiocheilus melanopterus Bleeker.Variation of amino acid sequences of serum amyloid A (SAA) and immunohistochemical analysis of amyloid A (AA) in Japanese domestic cats.Leukocyte Cell-Derived Chemotaxin 2-Associated Renal Amyloidosis: A Case Report.Deposition, Clearance, and Reinduction of Amyloid A Amyloid in Interleukin 1 Receptor Antagonist Knockout Mice.Kidney disease models: tools to identify mechanisms and potential therapeutic targets.Long-term kinetics of AA amyloidosis and effects of inflammatory restimulation after disappearance of amyloid depositions in mice.Apolipoprotein A-II induces acute-phase response associated AA amyloidosis in mice through conformational changes of plasma lipoprotein structure.

P2860

Q26770744-06B6BDB1-6604-4423-A8F9-95AA92CE6ADD Q26776120-2270913D-3D11-498B-AF3D-8D95EC1031EB Q28302517-D8BB81E3-FC7D-4CCD-AF75-84358D125C34 Q28601268-488FDCB9-76E2-4CC9-AAD5-E3FCD7E93C86 Q34579925-AC1246C1-ADE4-4D90-990F-B3B46AF5B87C Q35165468-2F5101A6-9D69-4256-8893-EA3DF36D4810 Q35227671-8BE651AC-ED1B-4E0C-80FD-0A54E56DC9C1 Q35448094-95DDD718-C891-4157-A90B-4AA4B7FC82FF Q36167581-2D3E7B94-BC49-4B4F-822D-F23EB6590126 Q36287560-24EBE7DE-03E4-42BC-A71E-883101AE41B4 Q36723137-C7CA987A-825F-4D9F-AC99-3915C51E3E39 Q36761783-C4088E5D-4B2B-44FC-BDC1-57D20B1CBAFC Q36913150-CF042CD3-D912-45BE-BB41-F2B054A5935D Q37236611-EF3F9061-ED79-49B1-B2C2-37BF4D8AA0CC Q38644004-00E6C9D8-DED3-4764-9C7E-44D6007FA26B Q38761950-BA7035D8-6719-4061-B2CB-16C337F2180A Q40707030-536C281F-4FFE-4A17-9BA2-B687A2A33317 Q46362635-DADF044B-B911-4E96-928B-0F3DF52821C4 Q47336870-6ECF5405-652F-4F18-97A1-EF99B18B4CDD Q49724267-EDE8B812-F8BA-44E6-90E1-E19D2DBE16DD Q51548302-39E5CD9C-CACF-4AD5-B8C3-FBBE358AB17E Q52668596-21B08CEB-47C6-4A4E-9C20-B645953C6F02 Q53590154-3FACDFF4-C724-4F55-99A3-B4800CA952DD Q55089258-60469472-BC56-4D37-915B-32BC55468D47

P2860

Pathogenetic mechanisms of amyloid A amyloidosis.

http://www.wikidata.org/entity/Q37218553

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pathogenetic mechanisms of amyloid A amyloidosis.

@en

Pathogenetic mechanisms of amyloid A amyloidosis.

@nl

type

label

Pathogenetic mechanisms of amyloid A amyloidosis.

@en

Pathogenetic mechanisms of amyloid A amyloidosis.

@nl

prefLabel

Pathogenetic mechanisms of amyloid A amyloidosis.

@en

Pathogenetic mechanisms of amyloid A amyloidosis.

@nl

P1433

Q37218553-5A31AD41-5642-4471-BA64-96AF1280D29D

P1476

Q37218553-74338F65-4A22-4BB9-876D-0B5D235A3397

P2093

Q37218553-081F6042-FC1E-4F22-B55F-A9A72672A5CF

Q37218553-173A3237-39FE-49F4-A91F-304C17826AB9

Q37218553-1C94EFC4-8895-4969-84C0-940BDBA89FC7

Q37218553-2EAF1675-B8BD-401C-BE59-D65029D5727E

Q37218553-3781EB0C-8FCE-47CA-B0C7-B58DF0B7DA15

Q37218553-406126E5-5376-4C1B-A4AA-851D76CF414D

Q37218553-674A9AEF-BA93-44D3-87AA-0DDB4D2A1CEE

Q37218553-68EB6A14-10BB-4A5A-BA0B-82B01B959FCC

Q37218553-6B51ED89-4170-481E-9825-F6BD1CB180C3

Q37218553-70826639-023C-4F90-A0D3-582B77A239A5

P2860

Q37218553-0429D2A2-A927-424F-AC15-F14A9BAE471C

Q37218553-13A38752-11DE-4A14-802B-514FFB5AE30E

Q37218553-26C996D3-9C42-4C7E-AA6E-C909F964C23C

Q37218553-33BFC113-610C-49BA-BECF-FF42635DD425

Q37218553-357A269B-4F80-4A17-B46A-48FC9EA55F15

Q37218553-3B0D3D83-FCB1-494F-A33F-BC689D7484B1

Q37218553-43F1C519-3B49-4D30-9EAA-6C2F92C32905

Q37218553-47C6AFF5-E54E-490B-8AB2-D403DB9C8B9C

Q37218553-52D2EAF3-EB1E-4EBA-99B8-74CA0F182DCF

Q37218553-53EB9A7D-9875-4FC5-8CE4-CBB36BB92630

P304

Q37218553-1C7C311E-C930-456D-A51D-899650C2FB0A

P31

Q37218553-A93F1295-0A9F-4458-88CA-5A2DFB27CB73

P356

Q37218553-BD033CB1-21F5-4DD2-B706-2780D139D88C

P407

Q37218553-1EF96B05-2A4B-4777-BAE7-6C12FE2ECA91

P433

Q37218553-2EA836E8-C53D-485E-B3B6-31ABF32A3C15

P478

Q37218553-C9CFF451-3022-4F42-A460-2A24E3AB8065

P50

Q37218553-63DF163B-B162-4E36-B329-56AD32FE9C1B

Q37218553-7281D98A-C220-48BC-89AB-347C8B13B63C

Q37218553-A3F1E4C8-73A5-45AE-9118-2A8F507DE181

P577

Q37218553-83A00235-0268-48CB-A3AD-AD6A043EE5CF

P5875

Q37218553-F9646F97-41C2-4309-B2FC-DF5769491AC6

P698

Q37218553-7A309886-A4BA-4FAE-8E61-E4F7BE7F1655

P921

Q37218553-99EC5D10-1FBA-453D-9D50-BD8174BF227B

P932

Q37218553-13F7ABAA-A847-48DC-9B92-B62C69066E64

P356

PNAS.1306621110

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Pathogenetic mechanisms of amyloid A amyloidosis

@en

P2093

David J Millar

http://www.w3.org/2001/XMLSchema#string

Ivana Speck

http://www.w3.org/2001/XMLSchema#string

Janet A Gilbertson

http://www.w3.org/2001/XMLSchema#string

Karl Bodin

http://www.w3.org/2001/XMLSchema#string

Palma P Mangione

http://www.w3.org/2001/XMLSchema#string

Philip N Hawkins

http://www.w3.org/2001/XMLSchema#string

Raya Al-Shawi

http://www.w3.org/2001/XMLSchema#string

Samrina Aslam

http://www.w3.org/2001/XMLSchema#string

Shane Minogue

http://www.w3.org/2001/XMLSchema#string

Stephan Ellmerich

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations

NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder

Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity

Amyloidogenesis. One serum amyloid A isotype is selectively removed from the circulation

Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene

Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.

Antibodies to human serum amyloid P component eliminate visceral amyloid deposits.

Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1.

Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component.

Unicentric Castleman's disease complicated by systemic AA amyloidosis: a curable disease.

P304

16115-16120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1306621110

http://www.w3.org/2001/XMLSchema#string

P407

P433

40

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-08-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255985708

http://www.w3.org/2001/XMLSchema#string

P698

23959890

http://www.w3.org/2001/XMLSchema#string

P921

P932

3791773

http://www.w3.org/2001/XMLSchema#string